Q1 2026 Holdings
Filed 2026-05-15 | 29 holdings | $903.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $163.4M | 1,946,667 | 18.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $90.5M | 2,350,000 | 10.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $75.4M | 677,000 | 8.3% |
| Alumis Inc(ALMS) | COM | 022307102 | $62.4M | 2,830,700 | 6.9% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $46.1M | 2,440,000 | 5.1% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $45.5M | 1,971,054 | 5.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $39.6M | 8,859,911 | 4.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $35.4M | 425,000 | 3.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $31.3M | 338,900 | 3.5% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $30.6M | 1,748,000 | 3.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $29.8M | 750,000 | 3.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $29.2M | 1,450,000 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $28.5M | 490,000 | 3.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $27.9M | 530,000 | 3.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $26.8M | 3,166,600 | 3.0% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $18.0M | 10,276,317 | 2.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $17.7M | 1,485,000 | 2.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $17.3M | 270,000 | 1.9% |
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $17.2M | 960,847 | 1.9% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $13.8M | 5,250,000 | 1.5% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $12.3M | 2,236,732 | 1.4% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $12.0M | 574,200 | 1.3% |
| Unicycive Therapeutics Inc(UNCY) | COM NEW | 90466Y202 | $6.6M | 1,000,000 | 0.7% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $6.4M | 719,000 | 0.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $6.3M | 1,100,000 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $4.7M | 165,000 | 0.5% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.3M | 791,555 | 0.4% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $3.3M | 143,472 | 0.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.5M | 7,750,000 | 0.3% |